MIRA INFORM REPORT

 

 

Report Date :

15.04.2014

 

IDENTIFICATION DETAILS

 

Name :

APEX LABORATORIES PRIVATE LIMITED (w.e.f. 08.04.2008)

 

 

Formerly Known As :

APEX LABORATORIES LIMITED

 

 

Registered Office :

3rd Floor, SIDCO Garment Complex, Guindy, Chennai – 600 032, Tamilnadu

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

15.07.1978

 

 

Com. Reg. No.:

18-007554

 

 

Capital Investment / Paid-up Capital :

Rs.13.719 millions

 

 

CIN No.:

[Company Identification No.]

U85195TN1978PTC007554

 

 

PAN No.:

[Permanent Account No.]

AAACA5174G

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in manufacturing and marketing of Pharmaceutical Formulations.

 

 

No. of Employees :

Not Available [We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (34)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 2753000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

The rating takes into consideration company’s moderate financial risk profile and increased in external borrowing of the company over previous year.

 

However, trade relations are fair. Business is active. Payment terms are slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

US investment bank Goldman Sachs has upgraded its outlook on Indian markets as it expects positive impact of the election cycle.

 

India’s economy may grow 4.7 % in the current financial year, lower than the official estimate of 4.9 %, Fitch Rating said. The global rating agency expects the economy to pick up in the next two financial years.

 

Global ratings agency Standard & Poor said increasing focus by India Inc on lowering debt is likely to improve their credit profiles.

 

Singapore (1.1 million Indian tourists in 2012), Thailand (one million), the United Arab Emirates ().98 million) and Malaysia ().82 million) emerged as the preferred holidays hotspots for Indians. The total figure is expected to increase to 1.93 million by 2017, according to the latest Eurmonitor international report.

 

There is a $29.34 bn outward foreign direct investment by domestic companies between April and January of 2013/14 which has seen some signs of recovery according to a Care Ratings report.

 

There are 264 number of new companies being set up every day on average during 2014. Most of them are registered in Mumbai. India had 1.38 million registered companies at the end of January, 2014.

 

Twitter like messaging service Weibo Corporation has filed to raise $ 500 million via a US initial public offering. Alibaba, which owns a stake in Weibo is expected to raise about $ 15 billion New York this year in the highest profile Internet IPO since Facebook’s in 2012.

 

Bharti Airtel has raised Rs.2,453.2 crore (350 million Swiss Francs) by selling six-year bonds at a coupon rate of three per cent and maturing in 2020. This is the largest ever bond offering by an Indian company in Swiss Francs. Bharat Petroleum Corporation raised 175 million Swiss Francs by selling five year bonds at 2.98 % coupon rate in February.

 

Indian Oil Corporation plans to invest Rs 7650 crore in setting up a petrochemical complex at its almost complete Paradip refinery in Odhisha in three to four years. The company board is set to consider the setting up of a 700000 tonne per annum polypropylene plant at an estimated cost at Rs.3150 crore.

 

Global chief information officers at gathering in Bangalore in April to meet Indian startups at an event called Tech50 Watchout for Little Eye Labs-Facebook type deals in the making.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Rating: BB+

Rating Explanation

Moderate risk of default and high credit risk.

Date

August 16, 2013

 

 

Rating Agency Name

CRISIL

Rating

Short Term Rating: A4+

Rating Explanation

Minimal degree of safety and very high credit risk.

Date

August 16, 2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

INFORMATION DECLINED

 

Management non-cooperative

 

(Tel. No.: 91-44-42225000)

 

LOCATIONS

 

Registered Office :

3rd Floor, SIDCO Garment Complex, Guindy, Chennai – 600 032, Tamilnadu, India

Tel. No.:

91-44-42225000

Fax No.:

91-44-42225005

E-Mail :

viswanathan@apexlab.com

venkat@apexlab.com

apexlabs@vsnl.com

finance@apexlab.com

info@apexlab.com

Website :

http://apexlab.com

 

 

Factory :

Shed No.C-7, S.F.No:237/3A, Industrial Estate, Alathur, Kancheepuram District, Tamilnadu, India

 

 

DIRECTORS

 

AS ON 30.09.2013

 

Name :

Mr. Vanangamudi Sulur Subramaniam

Designation :

Managing Director

Address :

No.29, 4th Road, VGP Layout, Injambakkam, Chennai – 600 041, Tamilnadu, India

Date of Birth/Age :

03.04.1956

Date of Appointment :

03.02.1982

DIN No.:

00056717

PAN No.:

ABPPV7230H

 

 

Name :

Mr. Balakrishnan Ramalingam

Designation :

Director

Address :

‘VISVAAS’, Old No.9, New No.19, Singari Street, Mylapore, Chennai – 600 004, Tamilnadu, India

Date of Birth/Age :

20.09.1950

Date of Appointment :

29.07.1978

DIN No.:

00056550

PAN No.:

AAMBP0581B

 

 

Name :

Mr. Karthik Veerabadran

Designation :

Director

Address :

New No.10, Old No.27, Parameshwari Nagar, 2nd Streeet, Adyar, Chennai – 600 020, Tamilnadu, India

Date of Birth/Age :

27.12.1949

Date of Appointment :

29.07.1978

DIN No.:

00799996

PAN No.:

AHRPK9318F

 

 

Name :

Srinivasan Murali

Designation :

Director

Address :

New No.69, AG Block, Third Street, Anna Nagar, Chennai – 600 040, Tamilnadu, India

Date of Birth/Age :

28.03.1961

Date of Appointment :

23.02.2013

DIN No.:

01812061

PAN No.:

AAKPM0048E

 

 

Name :

Sulur Ponmudi Vigneswaran

Designation :

Whole-time Director

Address :

10/1A, S.S.V. Nagar, Kalangal Road, Sulur, Coimbatore – 641 402, Tamilnadu, India

Date of Birth/Age :

11/09/1983

Date of Appointment :

01.10.2012

DIN No.:

02404873

PAN No.:

AFNPV1956J

 

 

Name :

Mr. Sulur Rangasamy Thangavelu

Designation :

Director

Address :

No.10, Panchayat Office Road, Sulur, Coimbatore – 641 402, Tamilnadu, India

Date of Birth/Age :

18.11.1937

Date of Appointment :

03.09.1982

DIN No.:

02576585

 

 

Name :

Mr. Maletur Ramachandraiyer Swaminathan

Designation :

Director

Address :

Old No.25, New No.66, Southdher Street, Sulur Palladam, Coimbatore – 641 402, Tamilnadu, India

Date of Birth/Age :

12.08.1952

Date of Appointment :

03.09.1982

DIN No.:

02582810

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2013

 

Names of Shareholders

 

 

No. of Shares

Veerabadran Karthik

 

6059

Ramalingam Balakrishnan

 

6059

S.S. Vanagamudi

 

102920

S. Thangavelu

 

134

M.R. Swaminathan

 

134

S.S. Bhanumathy

 

473

S.S. Kalaimani

 

473

S. Murali

 

66

S.P. Kayalvizhi

 

2000

S.P. Devi

 

2000

S.P. Vijayalakshmi

 

2000

S.P. Vigneshwaran

 

14875

Total

 

137193

 

AS ON 30.09.2013

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in manufacturing and marketing of Pharmaceutical Formulations.

 

 

Products :

  • Multivitamins
  • Zincovit Tablets
  • Zincovit Syrup
  • Zincovit Drops
  • Haematinics
  • Zincofer Nuture
  • Zincofer Tablets
  • Zincofer Syrups
  • Trifer Tablets
  • Trifer Syrup
  • Trifer Drops
  • Cartivit Tables
  • Lozee
  • Betzeee
  • Ascazin
  • Herbal

 

 

PRODUCTION STATUS (AS ON 31.03.2011):

 

Particulars

Unit

Licensed Capacity

Installed Capacity

Actual Production

Tablets

Nos.

Not Applicable

975000000

476856046

Capsules

Nos.

Not Applicable

94800000

22288718

Oral Liquids

Nos.

Not Applicable

10500000

22941663

Topicals

Nos.

Not Applicable

7500000

6116215

 

Notes: Installed capacities are as certified by Management and have not been verified by the auditors as this a technical matter.

 

GENERAL INFORMATION

 

No. of Employees :

Not Available [We tried to confirm the number of employees but no one is ready to part any information from the company management]

 

 

Bankers :

  • Axis Bank Limited, Corporate Banking Branch, Ground Floor, Karumuthu Nilayam, No.192, Anna Salai, Chennai – 600 002, Tamilnadu, India
  • Bank of India, Cathedral Road Branch, 46 Cathedral Road, Chennai – 600 086, Tamilnadu, India
  • State Bank of India, Overseas Branch, No.86, Rajaji Salai, Chennai – 600 001, Tamilnadu, India
  • Standard Chartered Bank, 19, Rajaji Salai, Chennai – 600 001, Tamilnadu, India

 

 

Facilities :

Secured Loans

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

LONG-TERM BORROWINGS

 

 

Rupee term loans from banks

(Secured with Land and Building)

259.048

181.805

Loans taken for vehicles

(Secured by hypothecation of vehicles)

1.651

4.263

SHORT-TERM BORROWINGS

 

 

Rupee term loans from banks

582.856

387.219

Total

843.555

573.287

 

Notes:

 

LONG TERM BORROWINGS

a. Term loan 1 from State bank of India for MHRA plant project was taken during the year 2006-07 and carries interest rate 12.95% p.a. The loan is repayable in 78 monthly equal instalments of 2.900 millions each along with interest for the period and 25 instalments were due as at 31st March, 2013.

 

The said loan is secured by way of first charge on the assets created out -of the term loan including Equitable mortgage over factory land (50529.60 sq. ft.) and building (2,790 sq. ft.) at shed no. C-7, S.F.No:237/3A,at Industrial Estate, Alathur, Kancheepuram District (UK-MHRA Plant)

 

b. Term loan II from State bank of India for Research and development was taken during the year 2009-10 and carries interest rate 13.05%. The loan is repayable in 70 monthly equal instalments of Rs.1.000 million each along with interest for the period and 51 instalments were due as at 31st March, 2013.

 

The said loan is secured by way of First charge on the assets created out of the term loan including Equitable mortgage over ail that piece and parcel of land and Building bearing shed no. A-8, SIDCO Pharmaceutical Complex, Industrial Estate, Alathur- 603110, Chengalpattu Taluk, Kanchcepuram District Land measuring about 1.002 Acres with built up area comprised 11,000 sq. ft. in Survey no. 237/1, now falling under Survey No. 237/3A1A of Alathur village. (R and D Plant)

 

c. Term loan 111 from State bank of India for expansion and modernisation of existing factory unit was granted during the year 2011-12 and carries interest rate 13.15%. The loan is repayable in 78 monthly instalments along with interest for the period and all instalments were due as at 31st March, 2013.

 

The said loan is secured by way of first charge on the assets created out of the term loan including Equitable mortgage over:-

i) land and building (plinth area 6,900 sq. ft), at shed no: C-26, in the Industrial Estate, Alathur comprised in S.F.No.237/1, 2 and 3 part of the SIDCO Pharmaceutical Complex of Alathur Village, land measuring 1 acre (part-I of IV parts of Plant-I)

ii) land and building {4,500 sq. ft). ft shed no. B-23, In the Industrial Estate, Aluthur comprised in S.F.No.237 part of Alathur Village, Kancheepuram district, land measuring 1 acre (part-Il of IV parts of Plant-I)

iii) all that piece land parcel of land and Building bearing shed no. A-8, SIDCO Pharmaceutical Complex, Industrial Estate, Alathur-603110,

Chengalpattu Taluk, Kancheepuram District, Land measuring about 1.002 Acres with built up area comprised 11,000 sq ft in Survey No.237/1, now falling under Survey no. 237/3A1A of Alathur village. (RandD Plant)

iv) all that piece and parcel of the modules no. 10 and 11, totally measuring 2,045 sq ft with 2 car parking, with rectangular flat (2 nos.) in the ground floor of the building in Block no. 1, comprising 64 units with UDS of 1 /64 of 95,309 sq ft for each, ie.2,978.40 sq ft for 2 nos. at SIDCO Garments Complex, at Thiru Vi Ka Industrial Estate in Survey no. 83/Part-86 part and 88 part. Alandur block no 6, Mambalam-Guindy taluk and 5/2-part, 5/3-part, 5/4-part, 5/5-part, 5/7-part, 5/8-part, 6-part, 7/9-part and 7/ 1C part of Aland"' belt area situated at Alandur village, Alandur taluk,

Kancheepuram Dist.

v) factory land (48,351.60 sq.ft.) with building (10645 sq.ft.) situated at C-27 S No 237/1,2 and 3 SIDCO Industrial Estate, Alathtir. Thiniporur Taluk. Kancheepuram Dist.** (part-Ill of IV parts of Plant-I)

vi). all that piece and parcel of land and building bearing shed no. B22. SIDCO Industrial Estate, Alathur, Tiruporur Taluk Chngleput MGR district land measuring about 4,500 sq mt with built up area comprised of 5,940 sq ft in survey no 237 of Alathur village. (part-IV of IV parts of Plant-I)

 

Further all the term loans from State Bank of India are secured by way of second charge as equitable mortgage over residential flats at A5 and A6 (measuring 1280 sq. ft. each in the second and third floors- totally 2560 sq. ft) Block No. A Su-vey No 237/3 (part) SIDCO Pharmaceutical complex, Alathur - 603110.

 

Term loan is further secured by corporate guarantee of Vanan Pharma Private Limited and ARLAB (India) Private Limited, collateral securities and personal guarantees of Directors including managing director

 

d. The vehicle loans are secured by hypothecation of vehicle taken on loan.

 

SHORT TERM BORROWINGS

 

A) Cash credit from banks are secured by hypothecation of current assets in the form of raw materials, semi-finished goods, finished goods, stores/spares, receivables and other current assets and carries interest rate @ 12% to 14* p.a. Cash credits from banks are further secured by corporate guarantees of Vanan Pharma Private Limited and Arlab (India) Private Limited contra, securities and personal guarantees of Directors including managing director.

 

B) Short term demand loan and packing credit faculties carries interest at the rate of 12% and LIBOR+3% respectively. These loans are secured by way of mortgage of:

 

i) All that piece and parcel of land and building and electrical installations with power connections from TNEB bearing shed No: C 6, in the SIDCO Pharmaceuticals Industries Complex, Alathur; Land measuring an extent of 0.995 acres, together with building measuring an extent of 11,213.06 sq ft together with existing all electrical fittings and fixation thereon.

 

ii) All that piece and parcel of land and building bearing Plot NO 49 in the layout known as VGP GOLDEN BEACH PART III, situated at Old no.146, new no 49, Injambakkarn village, bearing Patta no.374. As per patta Survey No.15/179, land measuring an extent of 7500 square feet or thereabouts.

 

 

 

Banking Relations :

--

 

 

Financial Institution :

Electronica Finance Limited, 128/A, Plot No.3, Kailashchandra Apartments, Paud Road, Kothrud, Pune – 411 038, Maharashtra, India

 

 

Auditors :

 

Name :

T.D. Jain and D.I. Sakaria

Chartered Accountants

Address :

No.34, Keshaw Nivas, 3rd Floor, 1st Main Road, Gandhi Nagar, Bangalore – 560 009, Karnataka, India

PAN No.:

AAAFO2177L

 

 

Parties where control / significant influence exists (Significant interest entities):

  • A V Tech Exports Private Limited
  • Apex Exports Private Limited
  • Arlab India Private Limited, India (CIN No.: U24231TN1997PTC038534
  • Vanan Pharma Private Limited, India (CIN No.: U24231TN2002PTC049892)

 

 

CAPITAL STRUCTURE

 

AS ON 30.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

200000

Equity Shares

Rs.100/- each

Rs.20.000 millions

 

 

 

 

 

Issued, Subscribed and Paid-up Capital :

No. of Shares

Type

Value

Amount

137193

Equity Shares

Rs.100/- each

Rs.13.719 millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1) Shareholders' Funds

 

 

 

(a) Share Capital

13.719

13.719

13.719

(b) Reserves and Surplus

674.535

505.579

370.569

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

688.254

519.298

384.288

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

260.699

186.068

146.314

(b) Deferred tax liabilities (Net)

105.180

67.863

66.946

(c) Other long term liabilities

0.300

0.000

0.000

(d) Long-term provisions

15.381

10.970

6.408

Total Non-current Liabilities (3)

381.560

264.901

219.668

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

582.856

387.219

354.762

(b) Trade payables

284.264

107.458

93.718

(c) Other current liabilities

370.944

347.721

442.158

(d) Short-term provisions

38.093

22.605

28.958

Total Current Liabilities (4)

1276.157

865.003

919.596

 

 

 

 

TOTAL

2345.971

1649.202

1523.552

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

686.667

564.677

546.224

(ii) Intangible Assets

5.965

3.879

5.405

(iii) Capital work-in-progress

240.694

74.538

2.155

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

250.187

250.187

92.787

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

513.787

302.512

329.626

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

1697.300

1195.793

976.197

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

366.997

216.017

149.033

(c) Trade receivables

130.930

111.676

134.953

(d) Cash and cash equivalents

31.422

34.704

174.186

(e) Short-term loans and advances

100.063

71.730

49.627

(f) Other current assets

19.259

19.282

39.556

Total Current Assets

648.671

453.409

547.355

 

 

 

 

TOTAL

2345.971

1649.202

1523.552

 

 

PROFIT and LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Turnover

2915.163

2471.156

2034.023

 

 

Other Income

NA

NA

NA

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

293.701

250.593

NA

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

50.739

50.389

NA

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX

242.962

200.204

NA

 

 

 

 

 

Less

TAX                                                                 

74.006

65.194

NA

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX

168.956

135.010

119.983

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

FOB value of Exports

127.657

122.591

51.097

 

TOTAL EARNINGS

127.657

122.591

51.097

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

38.949

31.894

8.069

 

 

Capital Goods

26.448

22.549

33.221

 

 

Traded goods, spares and others

15.273

7.966

0.487

 

TOTAL IMPORTS

80.670

62.409

41.777

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

1231.52

984.09

874.55

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

Return on Total Assets

(PBT/Total Assets}

(%)

13.10

15.12

NA

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.35

0.39

NA

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

1.23

1.10

1.30

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.51

0.52

0.60

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns.)

(INR in Mlns.)

(INR in Mlns.)

Share Capital

13.719

13.719

13.719

Reserves & Surplus

370.569

505.579

674.535

Net worth

384.288

519.298

688.254

 

 

 

 

Long-term borrowings

146.314

186.068

260.699

Short term borrowings

354.762

387.219

582.856

Total borrowings

501.076

573.287

843.555

Debt/Equity ratio

1.304

1.104

1.226

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns)

(INR in Mlns)

(INR in Mlns)

Turnover

2034.023

2471.156

2915.163

 

 

21.491

17.968

 

 


NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns)

(INR in Mlns)

(INR in Mlns)

Turnover

2034.023

2471.156

2915.163

Profit

119.983

135.010

168.956

 

5.90%

5.46%

5.80%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

INDEX OF CHARGES:

 

S.

No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

ADDRESS

Service Request Number (SRN)

1

10483340

28/02/2014

50,000,000.00

AXIS BANK LIMITED

CORPORATE BANKING BRANCH, GROUND FLOOR, KARUMUTHU
NILAYAM, NO.192, ANNA SALAI, CHENNAI, TAMILNADU - 600002, INDIA

B98803703

2

10475144

27/01/2014

11,900,000.00

ELECTRONICA FINANCE LIMITED

128/A, PLOT NO.3,KAILASHCHANDRA APPARTMENTS, PAUD ROAD, KOTHRUD, PUNE, MAHARASHTRA - 411038, INDIA

B95324455

3

10428970

29/05/2013

197,735,300.00

STANDARD CHARTERED BANK

19, RAJAJI SALAI, CHENNAI, TAMILNADU - 600001, INDIA

B76226588

4

10279094

26/03/2013 *

150,000,000.00

STANDARD CHARTERED BANK

19, RAJAJI SALAI, CHENNAI, TAMIL NADU - 600001, INDIA

B72032329

5

90289238

06/03/2014 *

815,100,000.00

STATE BANK OF INDIA

OVERSEAS BRANCH, NO.86, RAJAJI SALAI, CHENNAI, TAMILNADU - 600001, INDIA

B98733892

6

90298331

14/03/2013 *

203,500,000.00

BANK OF INDIA

CHENNAI MID CORPORATE BRANCH, 4TH FLOOR, "TARAPORE TOWERS" 826, ANNA SALAI,, CHENNAI, TAMILNADU - 600002, INDIA

B73211237

 

* Date of charge modification

 

 

Note:

The registered office of the company has been shifted from 38/76, C.P. Ramasamy Road, Alwarpet, Chennai – 600 018, Tamilnadu to the present address w.e.f. 01.12.2012.

 

 

CORPORATE INFORMATION

 

The company) is a Private Limited company domiciled in India and Incorporated under provisions of the Companies Act, 1956. The company is engaged in the manufacturing and selling of pharmaceutical products. The company caters to both domestic and international markets.

 

PRODUCTION AND SALES

 

The turnover for the year has registered an increase from Rs.2471.156 millions for the year ended 31.03.2012 to Rs.2915.163 millions during the year ended 31.03.2013. There has been an increase of 17.96% in sales during the year. The Board is confident of achieving better performance in the years to come.

 

PERFORMANCE

 

The profit and Loss Account for the year ended 31.03.2013 shows a net profit (before tax) of Rs.242.962 millions after providing depreciation of Rs.50.739 millions. The company’s efforts to control costs have started paying off as can be seen in the increase in PAT margins.

 

 

CONTINGENT LIABILITIES NOT PROVIDED FOR (AS ON 31.03.2013):

 

• Guarantees given to bank for loan facilities sanctioned to Vanan Pharma Private Limited Rs.283.000 millions

 

• Letter of credit Rs.30.511 millions

 

• Estimated value of contracts remaining to be executed on capital account and not provided for Rs.477.735 millions

 

• Disputed statutory claims / levies including those pending with Commissioner (Appeals)/Court (Excluding interest leviable, if any): -

 

In respect of Excise Duty of Rs.0.547 million appealed before the High court by the Central Excise Department against the order passed by the CESTAT with regard to Duty on Physician Samples cleared during 1998-99, which is still pending.

 

In respect of Income Tax demands raised on regular assessment for the financial years 2006-07, 2007-08, 2008-09 and 2009-10 amounting to Rs.29.249 millions appealed before the Commissioner of Income Tax (Appeals) LTU, Chennai, which are yet to be decided. However the management is confident of favorable appeal orders.

 

In respect of Income Tax demand amounting Rs.3.180 millions pertaining to financial year 2004-05 appealed before High Court, Chennai, by the Income Tax department against order passed by ITAT, Chennai.

 

The Company is also involved in other lawsuits, claims, investigations and proceedings including patent and commercial matters, which arise in the ordinary course of business, however, there are no such matters pending that the company expects to be material in relation to its business.

 

 

FIXED ASSETS:

 

Tangible Assets

·         Land

·         Building

·         Plant and Machinery

·         Furniture and Fixtures

·         Office Equipments

·         Vehicles

·         Computer

Intangible Assets

·         Computer Software

·         Copyrights, Patents and Other Operating Rights

 

 

 

 


CMT REPORT (Corruption, Money Laundering and Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.27

UK Pound

1

Rs.101.10

Euro

1

Rs.83.74   

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

SMN


 

SCORE and RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

3

--RESERVES

1~10

4

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

34

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial and operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.